RecruitingNot ApplicableNCT06296017

Effectiveness of Conservative Interventions in the Treatment of Trigger Finger


Sponsor

Hacettepe University

Enrollment

54 participants

Start Date

Oct 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Experimental: Extracorporeal Shock Wave Therapy, Extracorporeal Shock Wave Therapy+ Trigger Finger Splint, and others for people with stenosing tenosynovitis and trigger finger. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExperimental: Extracorporeal Shock Wave Therapy

Extracorporeal Shock Wave Therapy (ESWT for short) application will be performed on A1 pulley at 15 Hz, 1000 shock wave impulses, and 2.0 bar level, for a total of 5 sessions, one week apart.

OTHERTrigger Finger Splint

A trigger finger splint that immobilizes the MCF joint will be recommended for the splint treatment group. The patient will be asked to use this splint throughout the day for 8 weeks.

OTHERExtracorporeal Shock Wave Therapy+ Trigger Finger Splint

Extracorporeal Shock Wave Therapy (ESWT for short) application will be performed on A1 pulley at 15 Hz, 1000 shock wave impulses, and 2.0 bar level, for a total of 5 sessions, one week apart. Also, A trigger finger splint that immobilizes the MCF joint will be recommended.


Locations(1)

Feray Karademir

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06296017


Related Trials